“…delivery of very low amounts of DNA), antigen-specific B cells may enrich antigen via their (antigenspecific) surface receptors and subsequently present antigen to T cells (predominantly CD4 þ T cells) in lymphatic tissues. 46,47,51,52 Assuming that in fact antigen-presenting B cells play an important role for the adjuvant activity of CCL19 in the mouse model used in our study, it still remains an open question as to why CCL19 leads to an amplification of CD8 þ T-cell responses in mMT mice, but not in WT mice. Nevertheless, it has been previously concluded from experimental mouse models 53,54 that B cells are crucial for the development of TH2 responses by triggering IL-4 production in T cells or that they may even suppress tumor immunity, 55 possibly by competition with other APC as has previously been suggested by Qin et al 56 Since Her2/neu-directed immune responses after gene gun immunization are mediated by T cells, antibodies and many other immune mechanisms, 44 Her2/neu-specific T cells in B-cell-deficient mice (which contain higher numbers of T cells than WT mice, data not shown) might partially compensate for the lack of anti-Her2/neu antibodies, thereby re-establishing a direct correlation between tumor protection and ex vivo T-cell responses.…”